Search results
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Zacks· 5 days agoGilead Sciences (GILD) experimental candidate, seladelpar, demonstrates significant improvements in liver disease progression and reduced itching in primary biliary cholangitis study.